Lexicon Pharmaceuticals beats by $0.21, beats on revenue

• Lexicon Pharmaceuticals (NASDAQ:LXRX): Q4 EPS of -$0.31 beats by $0.21.
• Revenue of $23.04M (-81.9% Y/Y) beats by $7.4M.
• Press Release
• Update: Shares are up 5% premarket on light volume.